By G HossainPosted on July 28, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The star of GSK’s Hengrui partnership is the COPD candidate HRS-9821, which will complement the pharma’s respiratory pipeline that’s anchored by the anti-asthma drug Nucala. GSK Bets Up To $12B for Multi-Program Cancer Pact With Hengrui Post navigation Sarepta Denies Latest Patient Death is Elevidys-Linked as FDA Launches ProbeRocket Pharmaceuticals Cutting 30% of Workforce